. 2016 Oct;5(5):422–428. doi: 10.21037/hbsn.2016.08.03

Table 1. Studies comparing living donor liver transplantation (LDLT) and deceased donor liver transplantation (DDLT) for hepatocellular carcinoma (HCC).

Author	LDLT vs. DDLT	Country	Year	Study period	Type of LT	Case number	Recurrence free survival				Criteria used	Outside Milan (%)	Difference in tumor characteristics	Median follow-up period (months)
Author	LDLT vs. DDLT	Country	Year	Study period	Type of LT	Case number	1-year	3-year	5-year	P	Criteria used	Outside Milan (%)	Difference in tumor characteristics	Median follow-up period (months)
Hu et al. (15)	LDLT > DDLT	China	2015	1999−2009	LDLT	389	78	64	62	<0.001	Hangzhou criteria	6	More aggressive in DDLT	16
Hu et al. (15)	LDLT > DDLT	China	2015	1999−2009	DDLT	6,471	66	49	42	<0.001	Hangzhou criteria	4	More aggressive in DDLT	15
Ninomiya et al. (16)	LDLT = DDLT	Japan (LDLT); USA (DDLT)	2015	2002−2010	LDLT	133	92	86	85	NS	Kyushu criteria	41	More aggressive in LDLT	76
Ninomiya et al. (16)	LDLT = DDLT	Japan (LDLT); USA (DDLT)	2015	2002−2010	DDLT	362	94	86	81	NS	Milan	34	More aggressive in LDLT	67
Xiao et al. (17)	LDLT = DDLT	China	2014	1999−2012	LDLT	84	85	56	53	NS	Hangzhou criteria	69	None	27
Xiao et al. (17)	LDLT = DDLT	China	2014	1999−2012	DDLT	276	73	49	45	NS	Hangzhou criteria	72	None	27
Park et al. (18)	LDLT < DDLT	Korea	2014	1999−2010	LDLT	166	89	−	81	0.045	UCSF	NA	None	35
Park et al. (18)	LDLT < DDLT	Korea	2014	1999−2010	DDLT	50	96	−	94	0.045	UCSF	NA	None	35
Sandhu et al. (19)	LDLT = DDLT	Canada	2013	1996−2009	LDLT	58	88	75	70	NS	Toronto criteria	28	None	38
Sandhu et al. (19)	LDLT = DDLT	Canada	2013	1996−2009	DDLT	287	86	75	70	NS	Toronto criteria	32	None	31
Kulik et al. (20)	LDLT < DDLT	USA	2012	1998−2010	LDLT	100	80	66	56	0.05	UNOS	59	More aggressive in LDLT	60
Kulik et al. (20)	LDLT < DDLT	Multi-center	2012	1998−2010	DDLT	97	90	81	73	0.05	UNOS	30	More aggressive in LDLT	60
Bhangui et al. (10)	LDLT = DDLT	France	2011	2000−2009	LDLT	36	100	89	88	NS	UCSF	27	None	58
Bhangui et al. (10)	LDLT = DDLT	France	2011	2000−2009	DDLT	120	93	89	86	NS	UCSF	21	None	50
Li et al. (14)	LDLT = DDLT	China	2010	2005−2009	LDLT	38	71	42	−	NS	UCSF	79	None	25
Li et al. (14)	LDLT = DDLT	China	2010	2005−2009	DDLT	101	76	41	−	NS	UCSF	68	None	25
Di Sandro et al. (13)	LDLT = DDLT	Italy	2009	2000−2007	LDLT	25	−	96	96	NS	Milan	20	None	−
Di Sandro et al. (13)	LDLT = DDLT	Italy	2009	2000−2007	DDLT	154	−	91	89	NS	Milan	31	None	−
Sotiropoulos et al. (21)	LDLT = DDLT	Germany	2007	1998−2006	LDLT	45	88	75	−	NS	UCSF	44	None	−
Sotiropoulos et al. (21)	LDLT = DDLT	Germany	2007	1998−2006	DDLT	55	−	81	−	NS	UCSF	−	None	−
Lo et al. (22)	LDLT < DDLT	Hong Kong	2007	1995−2004	LDLT	43	93	71	71	0.029	UCSF	26	More aggressive in LDLT	33
Lo et al. (22)	LDLT < DDLT	Hong Kong	2007	1995−2004	DDLT	17	100	100	100	0.029	UCSF	29	More aggressive in LDLT	33
Hwang et al. (23)	LDLT = DDLT	Korea	2005	1992−2002	LDLT	237	83	80	−	NS	−	27	None	26
Hwang et al. (23)	LDLT = DDLT	Multi-center	2005	1992−2002	DDLT	75	88	82	−	NS	−	29	None	45
Gondolesi et al. (3)	LDLT = DDLT	USA	2004	1988−2002	LDLT	36	82	74	−	NS	UNOS	53	None	15
Gondolesi et al. (3)	LDLT = DDLT	USA	2004	1988−2002	DDLT	165	90	83	−	NS	UNOS	−	None	15

DDLT, deceased donor liver transplantation; HCC, hepatocellular carcinoma; LDLT, living donor liver transplantation; LT, liver transplantation; UCSF, the University of California, San Francisco; UNOS, United Network for Organ Sharing